Navigation Links
Newsbriefs from the July issue of the journal Chest
Date:7/4/2011

COMBINATION ANTITHROMBOTIC THERAPY MAY INCREASE BLEEDING RISK

A new study suggests that the use of combination antithrombotic therapy may increase the risk of clinically relevant bleeding in patients with atrial fibrillation (AF). Researchers from the United Kingdom, the Netherlands, and France compared outcomes in 3,728 patients with AF receiving anticoagulation alone and 848 patients with AF receiving combination antithrombotic therapy (anticoagulant and antiplatelet therapy). Results showed that patients receiving combination therapy had a 2.3-fold increased risk of clinically relevant bleeding compared with anticoagulation therapy alone. Combination antithrombotic therapy also does not appear to reduce the risk of stroke. Results suggest that combination antithrombotic treatment is justified only in patients where the benefit of adding antiplatelet therapy to anticoagulant therapy outweighs bleeding risk. This article is published in the July issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians: Chest. 2011;140(1):146-155.


IDENTIFYING PULMONARY ARTERIAL HYPERTENSION EARLY REMAINS PROBLEMATIC

One in five patients diagnosed with pulmonary arterial hypertension (PAH) in the United States report symptoms for more than 2 years before diagnosis. PAH is a progressive and fatal disorder, and the disease is often advanced when recognized, especially in younger patients. Researchers from Intermountain Medical Center, the University of California, University of Pennsylvania, Baylor College of Medicine, Boston University, and Mayo Clinic studied 2,967 adult patients enrolled in the Registry to Evaluate Early Long-term PAH Disease Management (REVEAL), for an 18-month period. In 21.1% of patients, symptoms were experienced for more than two years before PAH was recognized. History of obstructive airways disease and sleep apnea were independently associated with delayed PAH recognition. Despite progress in understanding the cellular and genetic basis of PAH, researchers found that the onset of PAH before age 36 years was associated with the greatest likelihood of delayed disease recognition, especially in individuals with histories of common respiratory disorders. This article is published in the July issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians: Chest. 2011;140(1):19-26.


INDACATEROL MAY REDUCE EXACERBATIONS IN PATIENTS WITH MODERATE TO SEVERE COPD

New research shows that indacaterol is effective and well tolerated for patients with moderate to severe chronic obstructive pulmonary disease (COPD). Researchers at the University Health Network, Asthma and Airway Centre, in Toronto, ON, Canada; the University of Nebraska Medical Center; and Novartis evaluated the safety and tolerability of indacaterol, a once-daily, inhaled β2-agonist, compared with a placebo in 415 patients with moderate to severe COPD. Over a 1-year period, researchers found that therapy with indacaterol led to significant reductions in COPD exacerbations and as-needed albuterol use, and it was well tolerated. This article is published in the July issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians: Chest. 2011;140(1):68-75.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Related medicine news :

1. Newsbriefs from the April issue of the journal Chest
2. Emotional, Behavioral Issues Affect Many Kids in Foster Care
3. Breast Cancer Plus Other Health Issues Linked to Worse Outcomes
4. FDA Issues New Rules on Sunscreens
5. Ovarian cancer cells bully their way through tissue
6. Chest journal news briefs -- June 2011 issue
7. Hartford Program issues geriatric social work awards, forms VA partnership
8. ASGE and SHEA issue updated multisociety guideline on reprocessing flexible gastrointestinal endoscopes
9. Childhood Cancer Therapies Tied to Gastrointestinal Issues
10. MetLife Foundations grant bolsters media coverage for aging issues
11. Experts Issue Top 5 List for Better Primary Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... BOSTON, MA (PRWEB) , ... May 26, 2017 , ... ... Care Act (AHCA), which narrowly passed the U.S. House on May 4, would result ... would be expected under continued implementation of the 2010 Patient Protection and Affordable Care ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and ... this week that is focusing on the Peace Agreements being discussed by President Donald ... sprint in a race to try to speed up peace talks in the continuous ...
(Date:5/26/2017)... ... May 26, 2017 , ... Rob Lowe acts as host and helps educate ... is on hiking in American. Viewers can reconnect with America as it explores some ... , Many consumers have looked for an inventive new place for a family vacation, ...
(Date:5/26/2017)... ... ... “When the Stars Lead Home”: a poignant story of loss, determination, and perseverance. “When ... avid reader who lives in the Pacific Northwest with her husband, daughter, two dogs, ... She couldn’t be more grateful. , Twelve-year old Tizzy could not believe how quickly ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... year’s recipient of proceeds from its 14th Annual Clays for Kids fundraiser, to ... Road 30, Bennett, Colorado. , As part of BluSky’s partnership with The ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... May 22, 2017  Lilac Corp, the company ... the launch of a new website . ... of a clinical study that showed surprising clearance ... Gene-Eden-VIR/Novirin in individuals suffering from HPV warts, precancerous, ... there are no other treatments that clear the ...
(Date:5/18/2017)... , May 18, 2017  Two Bayer U.S. ... Association (HBA) during its recent 28 th ... City.  The event showcases HBA,s longstanding mission of furthering ... of healthcare. Cindy Powell-Steffen , senior ... U.S. Radiology division, and Libby Howe , a ...
(Date:5/15/2017)... ATLANTA , May 15, 2017  Amy Baxter ... the industry leader in noninvasive pain relief, was awarded ... MM&M magazine. Baxter was recognized at the MM&M ... New York City on May 10, ... helping the biopharma industry go "beyond the pill."  ...
Breaking Medicine Technology: